v3.26.1
Unaudited Condensed Consolidated Interim Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2026
Dec. 31, 2025
Current Assets    
Cash and cash equivalents $ 72 $ 57
Other receivables 17
Total Current Assets 832 841
Investment in unconsolidated entity 52 121
Total assets 884 962
Current Liabilities    
Trade payable 1,398 1,545
Other accounts liabilities 1,173 1,246
Liability to an unconsolidated entity 80 175
Warrants liability, net 194 127
Notes and Loan payable 1,466 1,817
Total Current Liabilities 4,311 4,910
Total Liabilities 4,311 4,910
Stockholders’ Deficit    
Common stock, 0.001 par value each: 27,692,308 shares authorized as of March 31, 2026 and December 31, 2025, respectively; issued and outstanding 7,942,407shares as of March 31, 2026 and 4,377,388 as of December 31, 2025. 8 4
Additional paid-in capital 56,921 55,836
Treasury Stock (33) (33)
Receipts on account of shares 71
Accumulated deficit (60,323) (59,826)
Total Stockholders’ Deficit (3,427) (3,948)
Total Liabilities and Stockholders’ Deficit 884 962
Related Party    
Current Assets    
Accounts Receivables – related parties 271 271
Other receivables – related parties $ 472 $ 513